CRISPR

CRISPR4-lepr

ID
ZDB-CRISPR-190718-1
Name
CRISPR4-lepr
Previous Names
None
Target
Sequence
5' - GGGCTGACGCTGACCAGAG - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
umo39 lepr
zf3068 lepr
zf3583 lepr
Expression
Gene expression in Wild Types + CRISPR4-lepr
No data available
Phenotype
Phenotype resulting from CRISPR4-lepr
No data available
Phenotype of all Fish created by or utilizing CRISPR4-lepr
Phenotype Fish Conditions Figures
muscle lepr expression decreased amount, abnormal leprumo39/umo39 (AB) standard conditions Fig. 1 from Hu et al., 2022
male organism liver lepr expression decreased amount, abnormal leprzf3068/zf3068 standard conditions Fig. 4 with image from Yang et al., 2019
whole organism fatty, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
whole organism increased weight, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
male organism decreased weight, abnormal leprzf3068/zf3068 standard conditions Fig. 4 with image from Yang et al., 2019
feeding behavior behavioral quality of a process, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
male organism skeletal muscle decreased mass, abnormal leprzf3068/zf3068 standard conditions Fig. 4 with image from Yang et al., 2019
eating behavior increased frequency, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
whole organism increased length, abnormal leprzf3583/zf3583 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
adipose tissue increased amount, abnormal leprzf3583/zf3583 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
adult feeding behavior increased occurrence, abnormal leprzf3583/zf3583 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
whole organism increased mass, abnormal leprzf3583/zf3583 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
male organism liver lepr expression decreased amount, abnormal leprzf3068/+ standard conditions Fig. 4 with image from Yang et al., 2019
male organism decreased life span, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
male organism skeletal muscle decreased mass, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism decreased life span, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism skeletal muscle decreased mass, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism hepatocellular carcinoma increased amount, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
male organism decreased life span, abnormal leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 4 with image from Yang et al., 2019
male organism skeletal muscle decreased mass, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
male organism decreased life span, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism decreased weight, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
hepatocyte cell population proliferation increased occurrence, exacerbated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism liver neoplastic, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
male organism hepatocellular carcinoma increased amount, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
hepatocyte cell population proliferation increased occurrence, abnormal leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
hepatocyte cell population proliferation increased occurrence, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism liver neoplastic, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism decreased weight, abnormal leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism liver neoplastic, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism decreased weight, abnormal leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism hepatocellular carcinoma increased amount, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism decreased life span, exacerbated leprzf3068/zf3068; gz32Tg chemical treatment by environment: doxycycline Fig. 4 with image from Yang et al., 2019
whole organism increased length, abnormal leprzf3583/zf3583; mc4rzf3584/zf3584 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
adipose tissue increased amount, abnormal leprzf3583/zf3583; mc4rzf3584/zf3584 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
adult feeding behavior increased occurrence, abnormal leprzf3583/zf3583; mc4rzf3584/zf3584 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
whole organism increased mass, abnormal leprzf3583/zf3583; mc4rzf3584/zf3584 increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
muscle socs3a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
skeletal muscle myoblast decreased width, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
adipose tissue decreased amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
whole organism ab11-mapk labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
muscle ab5-akt labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver ab5-akt labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
brain pomca expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
adipose tissue cd36 expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
adult feeding behavior decreased occurrence, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
liver increased size, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
muscle Ab8-stat3 labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
whole organism shortened, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
muscle rps6kb1b expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver slc2a2 expression increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver slc2a1a expression increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
blood glucose decreased amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
muscle irs2a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle slc2a1a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle Ab1-fbxo32 labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
brain oxt expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
muscle trim63a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
brain prl expression decreased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
muscle ab4-mapk labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
whole organism Ab10-cdh1 labeling decreased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
liver ab4-mapk labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver Ab8-stat3 labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle gck expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
whole organism viability, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
adipose tissue pparg expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
adipose tissue Ab2-lipe labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle ab-mf20 labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
adipose tissue socs3a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle acaca expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
trunk musculature D-glucose import decreased occurrence, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg chemical treatment by environment: doxycycline, chemical treatment by environment: glucosamines Fig. 5 from Fei et al., 2020
brain npy expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
brain asip2b expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
larval feeding behavior decreased occurrence, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg increased food availability, chemical treatment by environment: doxycycline Fig. 3 from Fei et al., 2020
liver D-glucose import increased occurrence, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg chemical treatment by environment: doxycycline, chemical treatment by environment: 2-deoxy-D-glucose Fig. 5 from Fei et al., 2020
muscle socs3a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
skeletal muscle myoblast decreased width, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
adipose tissue decreased amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
whole organism ab11-mapk labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
muscle ab5-akt labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle rps6kb1b expression decreased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver ab5-akt labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
adipose tissue cd36 expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle Ab8-stat3 labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver increased size, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
whole organism shortened, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
liver slc2a2 expression increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle slc2a1a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver slc2a1a expression increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle irs2a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle trim63a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle Ab1-fbxo32 labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle ab4-mapk labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
liver ab4-mapk labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
whole organism Ab10-cdh1 labeling decreased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
liver Ab8-stat3 labeling increased amount, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle gck expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
whole organism viability, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 4 from Fei et al., 2020
adipose tissue Ab2-lipe labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
adipose tissue pparg expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle ab-mf20 labeling amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
adipose tissue socs3a expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
muscle acaca expression amount, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 from Fei et al., 2020
trunk musculature D-glucose import decreased occurrence, ameliorated leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg chemical treatment by environment: doxycycline, chemical treatment by environment: glucosamines Fig. 5 from Fei et al., 2020
liver D-glucose import increased occurrence, abnormal leprzf3583/zf3583; gz26Tg/gz26Tg; gz32Tg/gz32Tg; zf3013Tg/zf3013Tg; zf3581Tg/zf3581Tg chemical treatment by environment: doxycycline, chemical treatment by environment: 2-deoxy-D-glucose Fig. 5 from Fei et al., 2020
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.